Ontario Genomics is a pivotal organization in Canada that plays a crucial role in advancing genomics research and fostering innovation. Established with the mission to catalyze the development and application of genomic-based solutions, Ontario Genomics connects industry, academia, and government to drive economic growth and improve the quality of life in Ontario and beyond. One of its primary functions is to provide grants and funding to support genomics research and its application in various sectors, including health, agriculture, and the environment. Ontario Genomics operates as a not-for-profit organization that is part of the Genome Canada network, which is a key funder of genomics and genomic-based technologies in Canada. The organization collaborates with a wide range of stakeholders to leverage genomics in addressing significant biological problems, fostering innovation, and enhancing the competitiveness of Ontario's and Canada's biotechnology and life sciences sectors. Funding and grants from Ontario Genomics are integral to achieving these goals. These opportunities are designed to support both the discovery and applied phases of genomic research and to promote the commercialization of genomics-based innovations. Ontario Genomics administers several funding programs that support various aspects of genomics research and its application in businesses and non-profits. Genome Canada, as a federal partner, provides substantial funding that is often matched by the provincial government, industry, and other stakeholders. One of the major funding initiatives is the Large-Scale Applied Research Project (LSARP) competition. This program targets projects that aim to deliver tangible benefits to society and the economy by integrating genomics with strategies in crucial sectors like health, agriculture, natural resources, and the environment. LSARP encourages collaboration between academia, industry, and other partners to ensure that the outcomes of genomics research are relevant and potentially transformative. Ontario Genomics also supports small and medium-sized enterprises (SMEs) through the Genomics Application Partnership Program (GAPP). This program is particularly beneficial for businesses and non-profits seeking to apply genomics-driven approaches to overcome challenges or to develop new products and services. GAPP focuses on projects that have the potential for economic gains and societal benefits within a short timeframe. By facilitating collaborations between academic researchers and end-users from various industries, GAPP ensures that genomics research translates into practical solutions with substantial impact. Furthermore, Ontario Genomics provides entrepreneurial and commercialization support through initiatives like the BioCreate program, which offers funding and expertise to start-ups and early-stage companies in the genomics and synthetic biology sectors. This program is specifically designed to nurture innovative ideas and accelerate their journey from concept to market-ready solutions. Beyond funding, Ontario Genomics plays a critical educational and advisory role for businesses and non-profits keen on exploring genomics. Through workshops, panel discussions, and one-on-one consultations, the organization helps demystify genomics and emphasizes its practical applications in addressing industry-specific challenges. Overall, Ontario Genomics functions as a catalyst for growth by providing substantial financial support and fostering collaboration among researchers, businesses, and non-profits. Its grants and funding initiatives are vital in advancing genomics research and translating scientific discoveries into tangible societal and economic benefits. By bridging the gap between research and implementation, Ontario Genomics drives innovation and positions Ontario as a leader in the global genomics landscape.